Why do COVID death rates seem to be falling?

Nature. 2020 Nov;587(7833):190-192. doi: 10.1038/d41586-020-03132-4.
No abstract available

Keywords: Medical research; SARS-CoV-2; Therapeutics.

MeSH terms

  • Adenosine Monophosphate / analogs & derivatives
  • Adenosine Monophosphate / therapeutic use
  • Age Distribution
  • Age Factors
  • Aged
  • Aged, 80 and over
  • Alanine / analogs & derivatives
  • Alanine / therapeutic use
  • Antibodies, Monoclonal, Humanized / therapeutic use
  • Betacoronavirus / drug effects
  • Betacoronavirus / pathogenicity
  • COVID-19
  • Coronavirus Infections / mortality*
  • Coronavirus Infections / prevention & control
  • Coronavirus Infections / therapy*
  • Coronavirus Infections / transmission
  • Dexamethasone / therapeutic use
  • Humans
  • Immunization, Passive
  • Intensive Care Units
  • Oxygen / administration & dosage
  • Oxygen / therapeutic use
  • Pandemics / prevention & control
  • Pneumonia, Viral / mortality*
  • Pneumonia, Viral / prevention & control
  • Pneumonia, Viral / therapy*
  • Pneumonia, Viral / transmission
  • Respiratory Distress Syndrome / complications
  • Respiratory Distress Syndrome / therapy
  • SARS-CoV-2
  • Time Factors
  • Ventilators, Mechanical

Substances

  • Antibodies, Monoclonal, Humanized
  • remdesivir
  • Adenosine Monophosphate
  • Dexamethasone
  • tocilizumab
  • Alanine
  • Oxygen

Supplementary concepts

  • COVID-19 serotherapy